These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1223 related items for PubMed ID: 26892523

  • 21. Cardiac-Specific Deletion of the Pdha1 Gene Sensitizes Heart to Toxicological Actions of Ischemic Stress.
    Sun W, Quan N, Wang L, Yang H, Chu D, Liu Q, Zhao X, Leng J, Li J.
    Toxicol Sci; 2016 May; 151(1):193-203. PubMed ID: 26884059
    [Abstract] [Full Text] [Related]

  • 22. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury.
    Russell RR, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH.
    J Clin Invest; 2004 Aug; 114(4):495-503. PubMed ID: 15314686
    [Abstract] [Full Text] [Related]

  • 23. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
    Ikizler M, Dernek S, Sevin B, Kural T.
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
    [Abstract] [Full Text] [Related]

  • 24. The heart is better protected against myocardial infarction in the fed state compared to the fasted state.
    Liepinsh E, Makrecka M, Kuka J, Makarova E, Vilskersts R, Cirule H, Sevostjanovs E, Grinberga S, Pugovics O, Dambrova M.
    Metabolism; 2014 Jan; 63(1):127-36. PubMed ID: 24140100
    [Abstract] [Full Text] [Related]

  • 25. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
    Chang W, Li K, Guan F, Yao F, Yu Y, Zhang M, Hatch GM, Chen L.
    J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
    [Abstract] [Full Text] [Related]

  • 26. Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury.
    Şentürk T, Çavun S, Avcı B, Yermezler A, Serdar Z, Savcı V.
    Atherosclerosis; 2014 Dec; 237(2):760-6. PubMed ID: 25463117
    [Abstract] [Full Text] [Related]

  • 27. Hearts lacking plasma membrane KATP channels display changes in basal aerobic metabolic substrate preference and AMPK activity.
    Youssef N, Campbell S, Barr A, Gandhi M, Hunter B, Dolinsky V, Dyck JRB, Clanachan AS, Light PE.
    Am J Physiol Heart Circ Physiol; 2017 Sep 01; 313(3):H469-H478. PubMed ID: 28667052
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia.
    Zhao P, Wang J, He L, Ma H, Zhang X, Zhu X, Dolence EK, Ren J, Li J.
    J Cell Mol Med; 2009 Aug 01; 13(8A):1513-25. PubMed ID: 19508385
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A small molecule AMPK activator protects the heart against ischemia-reperfusion injury.
    Kim AS, Miller EJ, Wright TM, Li J, Qi D, Atsina K, Zaha V, Sakamoto K, Young LH.
    J Mol Cell Cardiol; 2011 Jul 01; 51(1):24-32. PubMed ID: 21402077
    [Abstract] [Full Text] [Related]

  • 34. Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner.
    Pantos C, Bescond-Jacquet A, Tzeis S, Paizis I, Mourouzis I, Moraitis P, Malliopoulou V, Politi ED, Karageorgiou H, Varonos D, Cokkinos DV.
    Basic Res Cardiol; 2005 Mar 01; 100(2):154-60. PubMed ID: 15616764
    [Abstract] [Full Text] [Related]

  • 35. Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine. Comparison between low- and zero-flow ischaemia.
    El Banani H, Bernard M, Baetz D, Cabanes E, Cozzone P, Lucien A, Feuvray D.
    Cardiovasc Res; 2000 Sep 01; 47(4):688-96. PubMed ID: 10974217
    [Abstract] [Full Text] [Related]

  • 36. Trimetazidine-induced enhancement of myocardial glucose utilization in normal and ischemic myocardial tissue: an evaluation by positron emission tomography.
    Mody FV, Singh BN, Mohiuddin IH, Coyle KB, Buxton DB, Hansen HW, Sumida R, Schelbert HR.
    Am J Cardiol; 1998 Sep 03; 82(5A):42K-49K. PubMed ID: 9737485
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Trimetazidine in the Prevention of Tissue Ischemic Conditions.
    Kallistratos MS, Poulimenos LE, Giannitsi S, Tsinivizov P, Manolis AJ.
    Angiology; 2019 Apr 03; 70(4):291-298. PubMed ID: 29888611
    [Abstract] [Full Text] [Related]

  • 40. Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux.
    Xie H, Xu Q, Jia J, Ao G, Sun Y, Hu L, Alkayed NJ, Wang C, Cheng J.
    Biochem Biophys Res Commun; 2015 Mar 13; 458(3):632-638. PubMed ID: 25684185
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 62.